Similar articles for PMID: 19110415

Year	Number of Results
1990	1
1994	1
1998	1
2002	2
2003	7
2004	6
2005	13
2006	20
2007	20
2008	30
2009	29
2010	12
2011	17
2012	9
2013	9
2014	7
2015	9
2016	7
2017	8
2018	14
2019	7
2020	1
2021	3
2022	3
2023	2
2024	0

1

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis.

von Minckwitz G, Schwenkglenks M, Skacel T, Lyman GH, Pousa AL, Bacon P, Easton V, Aapro MS. von Minckwitz G, et al. Eur J Cancer. 2009 Mar;45(4):608-17. doi: 10.1016/j.ejca.2008.11.021. Epub 2008 Dec 26. Eur J Cancer. 2009. PMID: 19110415 Review.

2

Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy.

Aapro M, Schwenkglenks M, Lyman GH, Lopez Pousa A, Lawrinson S, Skacel T, Bacon P, von Minckwitz G. Aapro M, et al. Crit Rev Oncol Hematol. 2010 Jun;74(3):203-10. doi: 10.1016/j.critrevonc.2009.06.004. Epub 2009 Sep 11. Crit Rev Oncol Hematol. 2010. PMID: 19748281 Free article. Review.

3

Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.

Skarlos DV, Timotheadou E, Galani E, Samantas E, Grimani I, Lianos E, Aravantinos G, Xanthakis I, Pentheroudakis G, Pectasides D, Fountzilas G. Skarlos DV, et al. Oncology. 2009;77(2):107-12. doi: 10.1159/000229504. Epub 2009 Jul 21. Oncology. 2009. PMID: 19622901

4

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.

Weycker D, Malin J, Kim J, Barron R, Edelsberg J, Kartashov A, Oster G. Weycker D, et al. Clin Ther. 2009 May;31(5):1069-81. doi: 10.1016/j.clinthera.2009.05.019. Clin Ther. 2009. PMID: 19539108

5

Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States.

Lyman GH, Lalla A, Barron RL, Dubois RW. Lyman GH, et al. Clin Ther. 2009 May;31(5):1092-104. doi: 10.1016/j.clinthera.2009.05.003. Clin Ther. 2009. PMID: 19539110

6

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.

Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, Bootsma GP, Tjan-Heijnen VC. Timmer-Bonte JN, et al. J Clin Oncol. 2005 Nov 1;23(31):7974-84. doi: 10.1200/JCO.2004.00.7955. J Clin Oncol. 2005. PMID: 16258098 Clinical Trial.

7

Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: results from an integrated analysis.

Pettengell R, Schwenkglenks M, Bacon P, Lawrinson S, Duehrsen U. Pettengell R, et al. Hematol Oncol. 2011 Dec;29(4):177-84. doi: 10.1002/hon.982. Epub 2011 Jan 18. Hematol Oncol. 2011. PMID: 21246591

8

Impact of primary prophylaxis on febrile neutropenia within community practices in the US.

Hershman D, Hurley D, Wong M, Morrison VA, Malin JL. Hershman D, et al. J Med Econ. 2009 Sep;12(3):203-10. doi: 10.3111/13696990903238603. J Med Econ. 2009. PMID: 19723018 Free article.

9

Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.

Schippinger W, Holub R, Dandachi N, Bauernhofer T, Samonigg H. Schippinger W, et al. Oncology. 2006;70(4):290-3. doi: 10.1159/000094890. Epub 2006 Aug 4. Oncology. 2006. PMID: 16899982

10

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.

Tan H, Tomic K, Hurley D, Daniel G, Barron R, Malin J. Tan H, et al. Curr Med Res Opin. 2011 Jan;27(1):79-86. doi: 10.1185/03007995.2010.536527. Epub 2010 Nov 22. Curr Med Res Opin. 2011. PMID: 21091127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

209 results

Results by year